A Study of ACE-2494 in Healthy Subjects

Clinical trial NCT03478319 · COMPLETED

Trial details

NCT number: NCT03478319
Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2018-02-15
Primary completion: 2019-06-13
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.